Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is -1.16% vs -7.13% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -134.69% vs -79.50% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -101.54% vs -23.34% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 105.26% vs -29.63% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
Compare Quarterly Results Of Hunan Er-Kang Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -1.16% vs -7.13% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 39.33% vs -41.07% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -134.69% vs -79.50% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 94.88% vs -93.02% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -101.54% vs -23.34% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -105.41% vs -34.51% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 105.26% vs -29.63% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 95.00% vs 100.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






